MedPath

Value of Comprehensive Geriatric Assessment, clinical judgment, and performance status in the treatment of patients with epithelal ovarian carcinoma aged 70 years and older.

Completed
Conditions
Ovarian cancer FIGO IIB-IV
Registration Number
NL-OMON23843
Lead Sponsor
TweeSteden hospital, location Tilburg
Brief Summary

Maas HA, Kruitwagen RF, Lemmens VE, Goey SH, Janssen-Heijnen ML. Gynecol Oncol. 2005 Apr;97(1):104-9 The influence of age and co-morbidity on treatment and prognosis of ovarian cancer: a population-based study.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

1. Histological confirmed (extra) epithelial ovarian carcinoma FIGO IIB - IV. Tumors of borderline malignancy are excluded;

2. No prior treatment with cytostatic agents or radiotherapy;

Exclusion Criteria

No exclusion criteria mentioned in the protocol.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Able to undergo chemotherapeutic regime.
Secondary Outcome Measures
NameTimeMethod
1. Mortality;<br /><br>2. Functional decline;<br /><br>3. Preserved mobility.
© Copyright 2025. All Rights Reserved by MedPath